- Home
- NVCR vs ACLS Comparison
NVCR vs ACLS Comparison
Compare NVCR & ACLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- ACLS
- Stock Information
- Founded
- NVCR 2000
- ACLS 1995
- Country
- NVCR Switzerland
- ACLS United States
- Employees
- NVCR N/A
- ACLS N/A
- Industry
- NVCR Medical/Dental Instruments
- ACLS Industrial Machinery/Components
- Sector
- NVCR Health Care
- ACLS Technology
- Exchange
- NVCR Nasdaq
- ACLS Nasdaq
- Market Cap
- NVCR 1.9B
- ACLS 1.5B
- IPO Year
- NVCR 2015
- ACLS 2000
- Fundamental
- Price
- NVCR $19.11
- ACLS $56.34
- Analyst Decision
- NVCR Buy
- ACLS Buy
- Analyst Count
- NVCR 6
- ACLS 7
- Target Price
- NVCR $32.83
- ACLS $133.00
- AVG Volume (30 Days)
- NVCR 941.3K
- ACLS 618.1K
- Earning Date
- NVCR 07-24-2025
- ACLS 05-06-2025
- Dividend Yield
- NVCR N/A
- ACLS N/A
- EPS Growth
- NVCR N/A
- ACLS N/A
- EPS
- NVCR N/A
- ACLS 5.46
- Revenue
- NVCR $621,711,000.00
- ACLS $958,056,000.00
- Revenue This Year
- NVCR $5.56
- ACLS N/A
- Revenue Next Year
- NVCR $9.15
- ACLS $7.62
- P/E Ratio
- NVCR N/A
- ACLS $10.31
- Revenue Growth
- NVCR 18.27
- ACLS N/A
- 52 Week Low
- NVCR $14.17
- ACLS $40.40
- 52 Week High
- NVCR $34.13
- ACLS $158.61
- Technical
- Relative Strength Index (RSI)
- NVCR 58.46
- ACLS 48.51
- Support Level
- NVCR $18.66
- ACLS $57.40
- Resistance Level
- NVCR $20.06
- ACLS $61.03
- Average True Range (ATR)
- NVCR 0.86
- ACLS 2.08
- MACD
- NVCR 0.19
- ACLS -0.69
- Stochastic Oscillator
- NVCR 71.98
- ACLS 4.35
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.